Updates in relapsing-remitting MS from ECTRIMS 2025 examine lifestyle interventions, anti-CD20 therapies, efficacy of ...
Multiple sclerosis, which affects around one in 500 people in Switzerland, is an autoimmune disease in which immune cells ...
Once-yearly infusions of rituximab are as effective as twice-yearly dosing for sustained control of MS in a new phase 3 trial ...
People with MS are more than twice as likely to experience headaches, including migraines, than their healthy counterparts, ...
Research presented recently at the ECTRIMS Congress 2025 highlights the patient perspective on menopause and MS.
News-Medical.Net on MSN
Estradiol and estriol may protect nerve function in multiple sclerosis
About 100,000 of the estimated million people in the United States with multiple sclerosis (MS) have a progressive form of ...
Researchers have identified two compounds, K102 and K110, that could repair the nerve damage from multiple sclerosis. These drugs help regenerate the protective myelin sheath and balance immune ...
A well-established diabetes drug alleviated brain inflammation in a female mouse model of multiple sclerosis, suggesting the ...
US Weekly on MSN
Selma Blair Recalls Doctors Dismissing Her Early Multiple Sclerosis Symptoms as a Teen
Selma Blair’s lifelong health struggles were signs of multiple sclerosis that doctors wouldn't acknowledge until she was in ...
Hollywood actress Selma Blair's experience highlights how doctors dismissed her crippling pain and fatigue for years, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback